-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SHF/9v5Ga1wbxTFOgI5lf6NsqT9M+FNcSm3BTUpVcn7lLF/qaPPpp3YChvwanASJ GU0s9ARxXjHJwnrnAmKP7g== 0001140361-10-022412.txt : 20100520 0001140361-10-022412.hdr.sgml : 20100520 20100520161558 ACCESSION NUMBER: 0001140361-10-022412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100519 FILED AS OF DATE: 20100520 DATE AS OF CHANGE: 20100520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHMERTZLER MICHAEL CENTRAL INDEX KEY: 0001288952 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 10848101 MAIL ADDRESS: STREET 1: 1300 VALLEY ROAD CITY: NEW CANAAN STATE: CT ZIP: 06840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0303 4 2010-05-19 0 0001061983 CYTOKINETICS INC CYTK 0001288952 SCHMERTZLER MICHAEL C/O CREDIT SUISSE ELEVEN MADISON AVENUE NEW YORK NY 10010 1 0 0 0 Common Stock, par value $0.001 2010-05-19 4 S 0 16239 3.00 D 4403913 I See Footnote 2 Represents the average per share sale price. The post transaction share total of 4,403,913 is represented by the following: (a) 3,278,221 shares of Common Stock held by Credit Suisse First Boston Equity Partners, L.P.; (b) 916,345 shares of Common Stock held by Credit Suisse First Boston Equity Partners (Bermuda), L.P.; (c) 2,916 shares of Common Stock held by Credit Suisse First Boston U.S. Executive Advisors, L.P.; (d) 88,766 shares of Common Stock held by EMA Partners Fund 2000, L.P.; and (e) 117,665 shares of Common Stock held by EMA Private Equity Fund 2000, L.P. Such amounts include shares of Common Stock issuable upon exercise of warrants previously reported in May 2009. Mr. Schmertzler is a Managing Director of Aries Advisors, LLC, the sub-advisor to Credit Suisse First Boston Equity Partners, L.P. Mr. Schmertzler disclaims beneficial ownership of the shares held by entities affiliated with Credit Suisse except to the extent of his proportionate partnership or membership interest, if any, therein. Michael Schmertzler 2010-05-20 -----END PRIVACY-ENHANCED MESSAGE-----